FSTX Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (8 Mär 2023 @ 22:00):

F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments...

Stats
Tagesvolumen	0
Durchschnittsvolumen	747 281
Marktkapitalisierung	156.51M
EPS	$-0.840 ( Q3 \| 2022-11-10 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.89 (Sector) 42.63 (Industry) 24.32
ATR14	$0.459 (6.45%)

AADI -2.86%

ABCL -2.15%

ABCM 0.04%

ABEO -2.99%

ABIO 2.29%

ABOS -4.46%

ABSI -3.29%

ABUS -0.65%

ABVX -3.34%

ACAD -1.76%

ACER -17.95%

ACET -2.00%

ACGN 1.29%

ACHL 1.43%

ACHV -1.90%

ACIU -3.37%

ACLX -4.07%

ACRV -3.19%

ACST -3.13%

ACXP -4.82%

ADAG -3.08%

ADAP -1.67%

ADGI 0.87%

ADIL -0.87%

ADMA 0.00%

ADPT 3.04%

ADTX 1.13%

ADVM 1.02%

ADXN -1.60%

AEON 5.94%

AEZS 0.22%

AFMD -3.54%

AGEN -2.36%

AGIO -1.19%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -5.20%

AKRO -1.47%

AKTX -25.54%

AKUS 0.00%

ALBO 0.00%

ALDX 1.22%

ALEC -5.01%

ALGS -6.06%

ALKS -1.83%

ALLK -1.67%

ALLO -8.05%

ALLR -34.80%

ALNA 3.16%

ALNY 7.74%

ALPN 0.02%

ALPX 0.00%

ALRN -1.64%

ALT 3.78%

ALVR -1.01%

ALXN 0.00%

ALXO 0.31%

ALZN -2.08%

AMRN 2.72%

AMTI -3.13%

ANAB -0.83%

ANEB 4.87%

ANGN 0.00%

ANIX -1.20%

ANL -3.22%

ANNX -3.98%

ANPC -3.15%

APGE -3.92%

APGN 8.48%

APGNW 30.65%

APLM -3.77%

APLS 5.15%

APLT -4.10%

APM 1.06%

APOP 0.38%

APRE 0.24%

APTO -1.43%

APTX 3.17%

APVO -6.12%

ARAV -13.39%

ARCT -3.88%

ARDS 2.28%

ARDX -3.68%

ARGX 2.49%

ARNA 0.00%

ARPO -0.90%

ARQT 8.11%

ARTL 11.29%

ARTLW 0.00%

ARVN -2.04%

ARWR -1.36%

ASLN -2.08%

ASMB -1.91%

ASND 4.95%

ATAI -3.57%

ATHA -7.59%

ATHE -0.83%

ATHX -33.50%

ATNF -0.66%

ATOS -3.74%

ATRA -6.10%

ATXI -2.72%

ATXS -1.74%

AUPH -1.59%

AURA -4.22%

AUTL -6.45%

AVBP -2.13%

AVEO 0.00%

AVIR -1.72%

AVRO -1.41%

AVTE -3.33%

AVTX 3.46%

AVXL -3.80%

AXLA 0.00%

AXSM 0.65%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.65%

BCAB -1.92%

BCDA 3.53%

BCDAW -39.75%

BCEL 0.00%

BCLI 3.13%

BCRX -3.03%

BCTX -13.88%

BCTXW -4.44%

BCYC -2.58%

BDRX -2.01%

BDTX -3.89%

BEAM -2.34%

BFRA -2.91%

BGNE -5.13%

BIOR -2.10%

BIVI -5.32%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -5.71%

BLTE -0.27%

BLU 0.03%

BLUE -7.08%

BMEA -6.13%

BMRN -0.20%

BNOX -9.25%

BNTC 0.00%

BNTX -2.57%

BOLD -18.11%

BOLT 0.18%

BPMC 0.42%

BPTH 0.48%

BPTS -13.47%

BRNS 0.74%

BRTX 2.91%

BTAI -0.84%

BTTX 1.35%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI -5.22%

CABA -13.47%

CADL -8.13%

CALA 0.00%

CALC 0.00%

CALT -1.18%

CAPR -3.13%

CARA -2.56%

CARM 2.68%

CASI -4.74%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -5.86%

CCCC 0.00%

CCXI 0.00%

CDAK 0.00%

CDIO -8.01%

CDIOW 24.00%

CDMO -1.53%

CDMOP 0.04%

CDT -15.17%

CDTTW -39.60%

CDTX 5.75%

CDXC -4.31%

CDXS -3.33%

CELC -1.02%

CELU -2.60%

CELUW 11.80%

CERC -1.68%

CERE -4.49%

CERO -14.81%

CEROW 0.60%

CFRX -27.95%

CGEM -5.47%

CGEN -3.21%

CGON -1.47%

CGTX -4.86%

CHMA -6.00%

CHRS -3.07%

CINC 0.00%

CING -3.46%

CINGW 34.95%

CKPT 0.48%

CLBS -16.75%

CLDX 0.11%

CLGN 0.59%

CLLS 1.05%

CLNN -5.91%

CLNNW 0.00%

CLRB -5.59%

CLSD 15.74%

CLSN -0.68%

CLVS 0.00%

CMMB 2.45%

CMND -7.46%

CMPI 0.00%

CMPX -4.50%

CMRA 0.00%

CMRAW 33.33%

CMRX 2.05%

CNCE 0.00%

CNSP 27.35%

CNST 0.00%

CNTA 0.00%

CNTB -3.62%

CNTX 0.46%

COCP -7.20%

COEPW 32.45%

COGT -6.41%

CORT -0.65%

COYA 4.24%

CPRX -1.56%

CRBP 1.93%

CRBU -5.88%

CRDF -4.24%

CRGX -4.30%

CRIS -4.39%

CRNX -1.73%

CRSP -3.43%

CRTX 2.63%

CRVO 0.00%

CRVS -2.73%

CSBR -1.59%

CTCX -11.35%

CTIC 0.06%

CTMX -9.02%

CTNM 3.86%

CTXR 5.10%

CUE -1.70%

CVAC 2.02%

CVKD -2.39%

CWBR 2.80%

CYAD -12.96%

CYCC -4.79%

CYCCP 5.49%

CYCN 5.02%

CYT -2.27%

CYTK -1.91%

CYTO -6.78%

DARE -2.35%

DAWN -0.96%

DBTX -0.81%

DBVT 0.91%

DFFN 10.28%

DICE 0.06%

DMAC 1.80%

DNLI -2.27%

DNTH -5.02%

DOMH 2.16%

DRMA -6.21%

DRMAW -1.25%

DRNA 0.00%

DRTS -1.82%

DRTSW 0.00%

DRUG 5.61%

DSGN -1.49%

DTIL 0.95%

DYAI -3.13%

EARS -1.77%

EDIT -2.17%

EDSA -3.71%

EFTR -1.06%

EFTRW 145.45%

EIGR -9.21%

ELAB -1.03%

ELDN -8.81%

ELEV -1.63%

ELOX -7.14%

ELTX -4.76%

ELVN -1.69%

ELYM -5.28%

ENGN -0.37%

ENGNW 18.81%

ENLV -3.55%

ENOB 1.79%

ENSC -3.98%

ENTA 0.25%

ENTO 1.69%

ENTX -9.22%

ENVB -7.29%

EPIX 0.00%

EPRX -2.97%

EPZM 0.00%

EQ 0.46%

EQRX -2.09%

EQRXW 0.00%

ERAS -3.70%

ERNA -1.64%

ERYP 1.30%

ESLA -0.65%

ESLAW 87.05%

ETNB -6.98%

ETON -1.20%

ETTX 0.00%

EVAX 6.44%

EVGN 0.58%

EVLO 0.00%

EWTX 4.07%

EXAI 0.95%

EXEL -0.27%

EYEG 0.04%

EYEN -2.23%

EYPT -3.05%

FATE -3.13%

FBIO -0.59%

FBIOP 0.32%

FBLG 0.00%

FBRX -6.12%

FDMT -5.38%

FENC -2.36%

FGEN -2.50%

FHTX -1.50%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -1.30%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -2.26%

FULC -5.68%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT 4.69%

GANX 0.78%

GBIO 1.43%

GBT 0.01%

GDTC -1.45%

GERN -1.53%

GHRS 0.84%

GLMD -2.79%

GLPG -2.10%

GLSI -0.77%

GLTO -6.44%

GLUE -0.52%

GLYC 25.28%

GMAB -0.15%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.81%

GNLX -0.88%

GNPX 0.99%

GNTA 3.94%

GOSS 22.26%

GOVX -27.39%

GOVXW -49.04%

GPCR -8.52%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -3.41%

GRTX 12.03%

GTHX -0.90%

GUTS -9.22%

GXGXW 41.67%

GYRE -3.78%

HALO 0.65%

HARP 0.09%

HCWB -1.65%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -2.68%

HOOK 0.30%

HOTH -4.46%

HOWL -10.34%

HRMY -0.07%

HRTX -4.09%

HSTO 0.00%

HUMA -3.33%

HUMAW 1.27%

IBRX -0.95%

ICCC 0.22%

ICPT 0.21%

ICU -19.90%

ICUCW -13.76%

ICVX -0.91%

IDRA -23.04%

IDYA -2.38%

IFRX -2.99%

IGMS -6.44%

IKNA 0.00%

IKT 0.40%

IMAB 0.00%

IMCR -1.09%

IMGN 0.02%

IMGO 0.00%

IMMP -1.13%

IMMX 1.75%

IMNM -3.35%

IMNN 2.34%

IMPL -27.27%

IMRA 15.96%

IMRN 0.00%

IMRX -4.03%

IMTX -1.64%

IMTXW 6.00%

IMUX -1.82%

IMV 0.00%

IMVT -0.29%

INAB 1.54%

INBX -2.46%

INCY -1.02%

INDP -1.80%

INFI -52.38%

INKT -1.11%

INM -6.35%

INMB -5.05%

INO -3.39%

INSM 1.87%

INTS 0.20%

INVA 0.88%

INZY -2.46%

IOBT 6.72%

IONS 5.19%

IOVA 3.55%

IPA 0.00%

IPHA -1.72%

IPSC -4.48%

IRON -1.04%

ISEE 0.38%

ITOS -1.81%

ITRM 3.42%

IVA 6.96%

IVVD -4.72%

JAGX 0.53%

JANX -4.05%

JAZZ -1.59%

JNCE 0.00%

JSPR -5.33%

JSPRW -16.18%

JUNS 0.00%

JUNSW 0.00%

KA -13.66%

KALV -1.45%

KDNY 0.22%

KMPH -0.34%

KNSA 0.53%

KNTE -0.38%

KOD -7.33%

KPRX 2.21%

KPTI -0.91%

KRBP -10.00%

KRON -6.43%

KROS -1.79%

KRRO -4.81%

KRTX 0.03%

KRYS 1.37%

KTRA 13.76%

KTTA 8.16%

KTTAW 0.92%

KURA -2.80%

KYMR -0.95%

KYTX -1.90%

KZIA -12.30%

KZR 0.97%

LABP 0.57%

LBPH -2.31%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.00%

LENZ -2.43%

LEXX -2.26%

LEXXW -14.63%

LGND -1.33%

LGNDV 0.00%

LGVN -2.08%

LIAN -8.28%

LIFE 2.70%

LIPO -23.38%

LIXT 0.77%

LIXTW -42.57%

LJPC -0.32%

LMNL 0.12%

LOGC 2.68%

LPCN -12.37%

LPTX -3.19%

LQDA -2.54%

LRMR -3.50%

LSTA 3.21%

LTRN 2.56%

LUMO -1.32%

LVTX 3.19%

LXEO -0.76%

LXRX -6.08%

LYEL -3.77%

LYRA -1.79%

MACK 0.10%

MBIO -12.31%

MBRX -0.71%

MCRB -1.11%

MDGL -1.39%

MDNA -13.16%

MDWD 0.55%

MDXG -0.15%

MEIP 2.88%

MESO -0.59%

MGNX -4.67%

MGTA -7.74%

MGTX -1.17%

MGX 3.61%

MIRM -4.91%

MIRO 0.59%

MIST -7.19%

MITO 0.00%

MLEC 7.41%

MLECW 23.81%

MLND -5.36%

MLTX 2.56%

MLYS -3.64%

MNKD -3.50%

MNMD -4.20%

MNOV 2.16%

MNPR 2.63%

MOLN 0.97%

MOR -1.71%

MORF 6.79%

MREO -6.91%

MRKR -1.49%

MRNA 0.44%

MRNS -0.73%

MRSN -4.98%

MRTX -0.17%

MRUS -0.23%

MRVI -2.83%

MTCR -1.29%

MTEM -2.88%

MTP -18.50%

MURA 0.31%

MYMD -1.60%

NAMS 0.20%

NAMSW 0.43%

NAUT 0.67%

NBRV 0.71%

NBSE -1.56%

NBTX 11.93%

NCNA -5.00%

NERV -2.15%

NEXI -1.06%

NGM -1.28%

NGNE -2.05%

NKGN 0.00%

NKGNW 8.00%

NKTR -8.55%

NKTX 9.46%

NLSP -7.12%

NLSPW 26.67%

NMRA -7.89%

NMTR -42.97%

NOVN -24.84%

NRBO 4.41%

NRIX -1.09%

NRSN 1.06%

NRSNW 0.00%

NRXP 0.75%

NRXPW 27.78%

NRXS -2.73%

NTBL -11.13%

NTEC -12.45%

NTHI 0.00%

NTLA -4.00%

NTRBW -31.07%

NUVL -0.30%

NVAX -0.14%

NVCT -1.39%

NVIV -34.28%

NXTC 1.19%

NYMX -0.05%

OABI -6.65%

OABIW -10.06%

OBIO -0.58%

OBSV 0.00%

OCEA 2.16%

OCGN -6.35%

OCS -0.30%

OCUL 0.46%

OCUP -4.38%

ODT -4.27%

OKYO -4.13%

OLMA -1.26%

OMER -4.77%

OMGA -0.83%

ONCO -2.22%

ONCR -3.08%

ONCS 31.87%

ONCT -1.87%

ONCY 0.00%

ONTX -0.47%

ONVO -5.06%

OPNT 0.00%

OPT -1.03%

ORGS -1.66%

ORIC -5.73%

ORMP 0.45%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -3.10%

OVID -11.39%

OYST 0.00%

PALI -3.25%

PASG 0.22%

PBLA 0.00%

PBM -4.22%

PBYI 1.37%

PCSA 6.92%

PCVX -1.69%

PDSB 10.49%

PEPG -6.00%

PGEN 3.73%

PHAR -6.99%

PHAS 0.00%

PHAT -4.62%

PHIO 2.30%

PHIOW 36.47%

PHVS 7.54%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -3.79%

PLUR -5.45%

PMN -5.66%

PMVP -0.59%

PNT 0.16%

PPBT -7.68%

PRAX -6.28%

PRDS 0.93%

PRLD -3.56%

PROG -3.47%

PROK -3.46%

PRQR 0.61%

PRTA -3.84%

PRTC -0.08%

PRTG -5.03%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV 1.86%

PSTX -6.18%

PTCT -1.73%

PTE -0.82%

PTGX -0.94%

PTIXW -5.10%

PULM 2.63%

PXMD -4.59%

PYPD 0.07%

PYXS -4.08%

QLGN -6.58%

QNCX -2.48%

QNRX -4.84%

QSI -2.50%

QSIAW -3.13%

QTTB -3.97%

QURE -1.76%

RAIN -1.63%

RANI -9.00%

RAPT -4.94%

RARE 1.09%

RCKT -0.87%

REGN 0.69%

RENB 1.26%

REPL 0.68%

RETA 0.02%

REUN -0.89%

REVB -10.42%

REVBU 3.46%

REVBW -38.46%

RGLS 4.39%

RGNX -3.67%

RIGL -11.87%

RLAY -2.32%

RLMD -0.33%

RLYB -3.25%

RNA -1.79%

RNAC 4.43%

RNAZ 1.96%

RNXT -1.74%

ROIV -0.73%

ROIVW 4.56%

RPHM -0.62%

RPRX -0.77%

RPTX -3.67%

RUBY 2.70%

RVLP -32.05%

RVMD 0.86%

RVMDW 5.10%

RVNC -8.56%

RVPH -1.56%

RVPHW -3.43%

RXDX 0.09%

RXRX 0.43%

RYTM 0.52%

RYZB 0.02%

RZLT -9.15%

SABS 0.00%

SABSW 0.25%

SAGE -5.71%

SANA -2.17%

SAVA -2.58%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -8.04%

SCPH -2.94%

SCPS 0.00%

SEEL 2.13%

SEER -1.73%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -4.94%

SGMT -1.43%

SGTX -2.56%

SIOX 22.63%

SLDB -12.39%

SLGL 8.36%

SLN -2.01%

SLNO -2.84%

SLRX 1.24%

SLS -3.31%

SMMT 0.13%

SNDX -1.31%

SNGX -21.60%

SNPX -3.13%

SONN -0.33%

SPPI -0.49%

SPRB 3.68%

SPRC -2.37%

SPRO 0.00%

SRNE -9.09%

SRPT -3.53%

SRRA 0.00%

SRRK -4.04%

SRZN -2.45%

STAB 0.00%

STOK -2.65%

STRO -2.61%

STSA 0.00%

STTK -10.11%

SURF -0.93%

SVRA 3.83%

SWTX 0.94%

SYBX 1.97%

SYRS -0.17%

TALS -0.73%

TARA -5.83%

TARS -2.36%

TBPH -4.22%

TCBP -9.85%

TCDA 0.00%

TCON 21.14%

TCRR 0.00%

TCRT -3.63%

TCRX -7.47%

TECH -1.91%

TENX 3.88%

TERN -3.59%

TFFP 3.68%

TGTX 4.24%

THRX 0.12%

TIL 0.00%

TLC 0.00%

TLSA 2.32%

TNGX -8.77%

TNXP 5.04%

TNYA -7.61%

TPST -1.44%

TRDA 3.72%

TRVI -1.14%

TRVN -2.41%

TSHA -7.33%

TSVT -2.59%

TTNP -0.91%

TVTX 2.18%

TYRA -0.88%

UBX 0.36%

UNCY -26.76%

URGN -5.61%

UTHR 0.03%

VACC 11.36%

VALN -4.35%

VAXX -5.88%

VBIV 3.23%

VBLT -8.77%

VCEL -2.81%

VCNX -6.47%

VCYT -0.92%

VERA 0.97%

VERU -6.67%

VERV -0.95%

VIGL -4.12%

VINC -3.01%

VIR 0.66%

VIRI -5.96%

VIRX -3.22%

VKTX -8.29%

VLON -13.04%

VNDA 2.68%

VOR 0.00%

VRCA -0.98%

VRDN -3.41%

VRNA -4.14%

VRPX -2.58%

VRTX -0.24%

VSTM -5.16%

VTGN 2.79%

VTVT -6.43%

VTYX -4.02%

VXRT -7.63%

VYGR -2.92%

VYNE 0.00%

VYNT 7.78%

WINT -3.24%

WVE -8.45%

XBIO -8.15%

XBIT 5.73%

XCUR -4.08%

XENE -1.10%

XERS -0.47%

XFOR -4.95%

XLO -3.30%

XLRN 0.00%

XNCR -3.68%

XOMA -5.07%

XOMAO 0.36%

XOMAP 0.73%

XRTX -3.29%

YMAB 1.16%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -1.23%

ZNTL -8.70%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2023-03-08	Kayitalire Louis	Sell	29 236	Common Stock
2023-03-08	Kayitalire Louis	Sell	25 019	Common Stock
2023-03-08	Kayitalire Louis	Sell	27 289	Stock Option (right to buy)
2023-03-08	Kayitalire Louis	Sell	12 880	Stock Option (right to buy)
2023-03-08	Kayitalire Louis	Sell	53 634	Stock Option (right to buy)

INSIDER POWER
-97.82
Last 100 transactions
Buy: 1 523 682 \| Sell: 2 468 516

Volumen Korrelation

Lang: 0.13 (neutral)

Kurz: 0.65 (weak)

Signal:(70.9) Neutral

F-star Therapeutics, Inc. Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

F-star Therapeutics, Inc. Korrelation - Währung/Rohstoff

-0.11
( neutral )

-0.02
( neutral )

-0.12
( neutral )

-0.35
( neutral )

0.18
( neutral )

-0.06
( neutral )

F-star Therapeutics, Inc. Finanzdaten

Annual	2021
Umsatz:	$21.17M
Bruttogewinn:	$0.00 (0.00 %)
EPS:	$-1.517

FY	2021
Umsatz:	$21.17M
Bruttogewinn:	$0.00 (0.00 %)
EPS:	$-1.517

FY	2020
Umsatz:	$11.26M
Bruttogewinn:	$0.00 (0.00 %)
EPS:	$-9.69

FY	2019
Umsatz:	$28.32M
Bruttogewinn:	$0.00 (0.00 %)
EPS:	$-2.54

Financial Reports:

No articles found.

F-star Therapeutics, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

F-star Therapeutics, Inc.

F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company\'s principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck cancer patients. It is also developing first-in-human clinical study of FS222, a bispecific antibody that is in Phase 1 clinical trial targeting the costimulatory CD137 receptor and the inhibitory PD-L1 ligand. In addition, the company is also evaluating FS120 and SB 11285 for patients with advanced cancers, which are under Phase 1 clinical trials. F-star Therapeutics, Inc. was incorporated in 2002 and is headquartered in Cambridge, the United Kingdom.